Search research articles
Contact Us
Filters
Showing results (51-60 of 144) with videos related to
Page
of 15
Sort By:
Progress in Clinical and Biological Research
|
January 1, 1986
Surgical techniques in the management of patients with superficial bladder cancer
M S Soloway, K H Kurth, H Herr, et al.
Marine Environmental Research
|
July 25, 2017
Marine debris in harbour porpoises and seals from German waters
B Unger, H Herr, H Benke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer
G Dalbagni, W Han, Z F Zhang, et al.
British Journal of Urology
|
March 1, 1997
Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II study
M S Cookson, P C Sogani, P Russo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract
P M Dodd, J A McCaffrey, S Hilton, et al.
Cancer
|
January 15, 1992
High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated
R J Motzer, S C Gulati, J P Crown, et al.
Science Robotics
|
November 7, 2020
On prosthetic control: A regenerative agonist-antagonist myoneural interface
S S Srinivasan, M J Carty, P W Calvaresi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma
P M Dodd, J A McCaffrey, H Herr, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 1, 1995
Neoadjuvant and adjuvant chemotherapy in advanced disease--what are the effects on survival and prognosis?
C N Sternberg, D Raghaven, Y Ohi, et al.
Cancer
|
December 15, 1990
The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors
R J Motzer, K Cooper, N L Geller, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 144) with videos related to
Sort By:
Page
of 15
Progress in Clinical and Biological Research
|
January 1, 1986
Surgical techniques in the management of patients with superficial bladder cancer
M S Soloway, K H Kurth, H Herr, et al.
Marine Environmental Research
|
July 25, 2017
Marine debris in harbour porpoises and seals from German waters
B Unger, H Herr, H Benke, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer
G Dalbagni, W Han, Z F Zhang, et al.
British Journal of Urology
|
March 1, 1997
Pathological staging and biochemical recurrence after neoadjuvant androgen deprivation therapy in combination with radical prostatectomy in clinically localized prostate cancer: results of a phase II study
M S Cookson, P C Sogani, P Russo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 16, 2000
Phase I evaluation of sequential doxorubicin gemcitabine then ifosfamide paclitaxel cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract
P M Dodd, J A McCaffrey, S Hilton, et al.
Cancer
|
January 15, 1992
High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better tolerated
R J Motzer, S C Gulati, J P Crown, et al.
Science Robotics
|
November 7, 2020
On prosthetic control: A regenerative agonist-antagonist myoneural interface
S S Srinivasan, M J Carty, P W Calvaresi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma
P M Dodd, J A McCaffrey, H Herr, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
June 1, 1995
Neoadjuvant and adjuvant chemotherapy in advanced disease--what are the effects on survival and prognosis?
C N Sternberg, D Raghaven, Y Ohi, et al.
Cancer
|
December 15, 1990
The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors
R J Motzer, K Cooper, N L Geller, et al.
Page
of 15